Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evogene Ltd. - Ordinary Shares (NQ:EVGN)

1.210 -0.050 (-3.97%)
Streaming Delayed Price Updated: 11:50 AM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Evogene Ltd. - Ordinary Shares

< Previous 1 2 3 Next >
Evogene Ltd (NASDAQ:EVGN) Reports Mixed Q2 2025 Results, Beats EPS Estimates But Misses on Revenue
Evogene (EVGN) reported Q2 2025 results, missing revenue estimates but beating on EPS. The stock saw a modest pre-market gain as investors focused on the narrower-than-expected loss. 
Via Chartmill
Earnings Scheduled For August 19, 2025
 
Via Benzinga
Preview: Evogene's Earnings
 
Via Benzinga
Evogene Becomes Talk Of Retail Town As Stock Doubles On GenAI Drug, Agri Discovery Model With Google Cloud
The company said its internal tests show a nearly 90% success in generating precise, novel molecules, vastly outperforming traditional generative AI models. 
Via Stocktwits
Topics Artificial Intelligence
Insights into Evogene's Upcoming Earnings
 
Via Benzinga
A Glimpse of Evogene's Earnings Potential
 
Via Benzinga
Evogene Earnings Preview
 
Via Benzinga
Recap: Evogene Q3 Earnings
 
Via Benzinga
Top movers in Tuesday's after hours session
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
Dow Gains 50 Points; US Small Business Optimism Index Rises In May
 
Via Benzinga
Topics Stocks
Which stocks are moving on Tuesday?
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
Which stocks are gapping on Tuesday?
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
A Preview Of Evogene's Earnings
 
Via Benzinga
Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know
 
Via Benzinga
US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results
 
Via Benzinga
These stocks that are showing activity before the opening bell on Tuesday.
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
Earnings Scheduled For May 21, 2025
 
Via Benzinga
Unusual volume stocks in Tuesday's session
On Tuesday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AI
Evogene's stock surged on news of ICL's acquisition of Lavie Bio's operations, strengthening ICL's position in ag-biologicals. 
Via Benzinga
Earnings Scheduled For November 21, 2024
 
Via Benzinga
EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024
EVGN stock results show that Evogene missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For March 6, 2025
 
Via Benzinga
EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024
EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. Despite a 12% revenue decrease in Q4, the Israeli cannabis company reported... 
Via Benzinga
Topics Cannabis
Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challenges
Evogene reports a strong Q3 with $3.8M revenue and significant gross profit growth, showcasing resilience and innovation in cannabis tech. 
Via Benzinga
Topics Cannabis
Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023
 
Via Benzinga
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
Why Evogene Shares Are Moving
Evogene Ltd (NASDAQ: EVGN) shares are trading lower by 5.9% to $0.63 Thursday morning after the company received a letter from the Nasdaq indicating that the company is not in compliance with the... 
Via Benzinga
Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets
Cannabis company Evogene Ltd. 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.